🟢 Humacyte is trading 5.49% up today in pre-market with no clear catalyst

Humacyte is trading at $0.60, up 5.49%, with no clear company-specific catalyst identified for September 25, 2026.

• Recent company releases concern an earlier September FDA shelf-life authorization and an upcoming conference presentation; neither is new overnight news.
• Major U.S. indices are only modestly higher, which does not clearly explain the move. Confidence in the reason for the gain is low.